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In 2002, Canada introduced routine, mandatory HIV
antibody screening for all residency applicants, including
selected children. We report screening results from
January 2002 to February 2005. Thirty-six pediatric HIV
cases were detected (14/100,000 applicants); 94% of
infected children were eligible to arrive in Canada. Thirty-
two of the affected children were from Africa, and maternal
infection was the main risk factor. Only 4 (11%) of the chil-
dren had received antiretroviral therapy. In countries of low
HIV incidence, migration-related imported infection in chil-
dren may be an emerging epidemic. The early identification
of HIV-infected immigrant women permits intervention to
prevent mother-to-child HIV transmission. Routine HIV
testing as a component of the medical examination of immi-
grants has national and international health policy and pro-
grammatic implications. 
I
n 2004, the Joint United Nations Programme on
HIV/AIDS reported that the number of persons living
with HIV and AIDS in the world was 39.4 million, 4.9 mil-
lion were newly infected with HIV, and 3.1 million had
died because of HIV/AIDS (1). Within these numbers are
an estimated 2.2 million children <16 years of age who are
living with HIV/AIDS. Globally in 2003, ≈640,000 new
HIV pediatric infections and 510,000 pediatric deaths
occurred. Most pediatric HIV/AIDS occurs in the develop-
ing world because of mother-to-child transmission, but
pediatric HIV/AIDS is also a concern in Western nations,
where several strategies have been developed and imple-
mented to prevent pediatric HIV infection and subsequent
AIDS-related disease. 
Alink between HIVinfection in hyperendemic zones of
the developing world and pediatric HIV infections in
Western countries is largely undocumented (2). Irregular
migrants (those who arrive by smuggling or trafficking)
and those seeking asylum in Europe represent a separate
epidemiologic pattern of HIV/AIDS introduction (3). For
regions without extensive immigration assessment pro-
grams, or where most international arrivals for permanent
residency are seeking asylum or are arriving through other
irregular means, migration-associated HIV/AIDS preva-
lence and the pediatric HIV/AIDS epidemic are emerging
policy and programmatic issues. Injection drug use and
sexual exploitation, particularly for women, are 2 potential
risks associated with illegal immigration status that
increase HIV exposure, with the potential consequence of
mother-to-child viral transmission (4).
Prearrival immigration medical screening has been
used to identify conditions such as tuberculosis, syphilis,
and HIV/AIDS that could affect admission to receiving
nations. Many immigrant-receiving nations in the industri-
alized world now have national policies designed to better
address the needs of vulnerable, foreign-born migrants or
to facilitate the immigration process for preferred appli-
cants. Nations who either have existing medical screening
programs or who are planning such programs are likely to
identify persons with HIV/AIDS. Decisions on screening
immigrants for HIV infection not only have direct implica-
tions for admissibility programs but also affect the need for
culturally and linguistically appropriate clinical and public
health services.
The 2002–2003 annual report of the Ministerial
Council on HIV/AIDS in Canada “estimated that 70% of
all maternal HIV transmissions to children in Canada have
occurred among women of African and Caribbean origin”
(5). From November 1985 to June 2004, the Public Health
Agency of Canada reported notification of 56,523 positive
HIV test results (6). From 1984 to 2002, it also reported
420 HIV infections in 1,584 children born to HIV-positive
mothers (7).
Apart from the potential for perinatal HIV exposure,
other pediatric risk factors for nonmaternal HIV acquisi-
tion in the industrialized world, such as blood transfusion,
tattooing, or illicit drug use, are rarely encountered or doc-
umented. Strategies designed to reduce mother-to-child
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screening programs for pregnant women (8), risk behavior
counseling, recommendations for antiretroviral treatment
to prevent mother-to-child-transmission or to treat a new-
born exposed to HIV at birth, conception control, and
birthing methods. These strategies have been relatively
successful in reducing pediatric HIV infections in most
industrialized nations but have been less effective in devel-
oping nations (9–11).
The role of population mobility between hyperendemic
HIV transmission zones and countries of lower prevalence
is emerging as a contributing factor in risk for pediatric
HIV infection between HIV high-prevalence and low-
prevalence regions. This article describes the results of the
first 3 years of a medical screening program for HIV anti-
bodies in selected children who were applicants for resi-
dency in Canada. The results of this study confirm that
mobile population dynamics between countries and
regions and demographic changes in pediatric HIV/AIDS
epidemiology are directly related and have consequences




Mandatory, routine serologic HIV testing of immi-
grants in Canada began in January 2002 as a component of
the Canadian immigration medical examination (12,13).
While routine testing was not conducted on applicants <15
years of age, those identified as being at risk in the pedi-
atric migrant populations were evaluated for HIV infec-
tion. An enzyme-linked immunoassay (EIA) HIV
screening test for HIV-1 and HIV-2 antibodies was
required for all children <15 years of age who had received
blood or blood products, had an HIV-positive mother, or in
the judgment of the assessing medical practitioner, was
noted to have any other identified HIV infection risk fac-
tor. Potential adoptees were also screened for HIV antibod-
ies until a policy decision changed this requirement in late
2004. Reflecting national and international legal processes
of adoption, international adoptees brought to Canada by
Canadian citizens or permanent residents of Canada are
considered part of the existing family, and although they
are required to apply for Canadian citizenship, they are
exempted from most immigration processes (including the
medical examination to determine inadmissibility).
The HIV-tested migrant groups included children of
applicants for permanent residence (immigrants and
refugees) and those who filed refugee or asylum claims in
Canada. Immigration medical screening, including routine
HIV testing for those >15 years of age is also required for
some other persons arriving in Canada, including visitors
staying >6 months from certain locations (e.g., tourists,
students, and seasonal workers). Children of persons in
this group could also be referred for HIV testing if risk fac-
tors were noted during the process (14).
Medical Assessment and HIV Testing Protocols
The guardians of all pediatric applicants were coun-
seled and consented to HIV testing. Venous blood was col-
lected and transported to an approved local testing facility.
HIV antibody was tested by EIA. Immunofluorescence
antibody testing and Western blot (or other approved man-
ufacturer’s EIA kit) testing on another blood sample were
used as confirmatory tests on positive or indeterminate
HIV antibody test results.
Data Management and Protection 
of Personal Information
Immigration medical screening data were provided by
Citizenship and Immigration Canada. Personal data were
protected according to national guidelines on information
privacy (15,16). Age was calculated from the date of birth
and application date on the immigration file. The 5 immi-
gration categories used in the analysis, reflecting current
Canadian classifications, were economic, family, refugee
(abroad), refugee claimant (in Canada), and other (17).
The “other” category includes temporary resident appli-
cants, such as visitors, workers, and students.
Currently, Canadian immigration policy reflects 3
major goals. New immigrants are selected on the basis of
1 of these 3 basic principles: reunification of families, eco-
nomic ability to become successfully established in
Canada, or humanitarian reasons based on displacement or
persecution. Specific components of each of these major
immigration selection groups are further described by leg-
islation and regulation (18).
Refugee claimants, known as asylum seekers in
Europe, differ from refugees whose convention-defined
status has been determined before arrival (19–21). Refugee
claimants arrive through uncontrolled and irregular means
and complete the immigration medical assessment
processes entirely within Canada as part of the procedures
for determining their refugee status. During the past
decade, the number of refugee claimants arriving in
Canada has varied from 23,000 to 43,000 claimants per
year (22). Since the implementation of the Safe Third
Country Agreement between Canada and the United States
on December 29, 2004, the number of refugee claimants
has declined by ≈25% (23).
Results
From January 2002 to February 2005, a total of
1,307,718 persons underwent a Canadian immigration
medical assessment (24), including 256,970 applicants
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six new HIV-positive diagnoses were made in the pediatric
applicant population; 18 were boys and 18 were girls.
Twelve HIV-positive applicants were <1 year of age at
diagnosis, 7 were 2–4 years, 7 were 5–7 years, 2 were 8–10
years, and 8 were 11–14 years. Median age for girls was 6
years (range from infancy to 14 years) and for boys, 4
years (range from infancy to 12 years). All HIV-infected
children except 4 (2 from Europe, 2 from Asia/Pacific
Islands) identified a country in Africa as either their par-
ents’ home or their country of birth. Twenty-seven (75%)
of the 36 HIV-infected children were tested because of
known maternal HIV positivity, 6 children (17%) were
tested because of adoption, 2 (6%) were tested because of
an HIV-positive sibling, and 1 (3%) was detected because
of concurrent treatment for tuberculosis. Two girls (ages 6
and 12 years) and 2 boys (ages 6 and 11 years) (11%) had
documentation of having received highly active antiretro-
viral therapy (HAART). Two of the 4 received HAART in
North America, 1 in the United Kingdom, and 1 in
Ethiopia. By applicant category, 2 of the children receiving
HAART were family class, 1 was a refugee claimant, and
1 was an economic applicant.
HIV-positive children by immigration category and
year of testing are shown in the Table. Refugees represent-
ed 26 (72%) of the 36 HIV diagnoses, family class repre-
sented 7 (19%), and economic, refugee claimant, and
temporary resident applicants represented 1 case each
(3%). Only 2 HIV-infected children were processed in the
immigration medical office responsible for North America,
which indicates their application originated in Canada or
the United States.
Thirty-three (92%) of the 36 HIV pediatric cases
occurred in populations deemed to be eligible for admis-
sion to Canada, despite medical status, on the basis of
these application categories (26 in the refugee class and 7
in the family class). Of those children found to be HIV
positive in the study period, 24 (66%) had arrived in
Canada.
Discussion
In the context of all immigration applicants, 36 HIV-
infected children were identified. During the study,
256,970 applicants <15 years of age underwent medical
examinations. This number represents a crude ratio of
14/100,000 pediatric applicants from January 2002
through February 2005. A ratio per tested pediatric appli-
cant cannot be determined because negative serologic test
results are not recorded for this age group, and no estimate
of the tested population size is possible because of varia-
tions in medical examiner and adjudicator practices during
the study. All but 4 of the pediatric HIV -positive appli-
cants were originally from Africa (89%), which reflects the
relationship between population flow and the global epi-
demiologic features of HIV infection and disease (25). In
contrast, domestically reported pediatric HIV cases are
rare in Canada (0.02/100,000 general population).
Applicants in the refugee (26 cases) and family (7
cases) categories accounted for 33 (91%) of the 36 HIV
diagnoses in this study period. The refugee and family cat-
egories are exempted from provisions that can render
applicants inadmissible because of medical reasons.
Consequently, the 33 children in these groups were all
medically eligible to be admitted to Canada. When those
children are combined with the HIV-positive pediatric
refugee claimant who was in Canada when tested, 34
(94%) of the 36 HIV-infected children detected during the
first 3 years of the mandatory immigration screening pro-
gram were medically admissible or had already arrived in
Canada.
In the 2004 World Health Organization report,
Canadian public health officials estimated an overall HIV
prevalence ratio in Canada of 3–5 cases per 10,000 preg-
nant women on the basis of pregnancy HIV screening
results (26). Fecundity data in Canada from 1986 to 2001
show that 1,197,300 children were born to Canadian-born
women and 337,700 children were born to immigrant
women (1,535,000 total newborns) (27). If the estimated
HIV prevalence rate for pregnant women in Canada is
applied to the average of 102,333 newborn children per
year, an estimated 92–154 singleton births occur to at-risk
pregnant women.
The actual number of documented mother-to-child HIV
exposures reported in Canada has been less than that fig-
ure. From 1984 to 2002, national statistics in Canada show
that 1,584 infants (an average of 88 per year) were perina-
tally exposed to HIV. Of these infants, 420 have been
reported as HIV infected. An additional 120 children had
unconfirmed HIV status, including those with indetermi-
nate serologic status, those who died, or those who were
lost to follow-up. As a possible reflection of the effective-
ness of the national perinatal HIV screening, mother-to-
child transmission–prevention programs, and other factors,
<4% of at-risk pregnancies in HIV-positive mothers result-
ed in viral transmission to their newborns in 2001 and
2002, with only 12 pediatric HIV cases reported in those 2
years (0.02 cases/100,000 population per year).
As indicated in this study of immigrant applicants,
more HIV-infected children are detected through selective
immigration medical screening in migrant pediatric popu-
lations arriving or arrived in Canada. Growing global pop-
ulation mobility and immigration could more than double
the annual domestic pediatric HIV/AIDS caseload in
Canada.
Despite the success of industrialized nations’ domestic
mother-to-child transmission prevention programs, the
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Western society. For several reasons, including education,
language, culture, and fear of personal and social reprisals,
foreign-born migrant women may have limited access to
healthcare services or delay medical care. They may not be
able to fully access prenatal care or HIV screening pro-
grams that could benefit them and their unborn children
(28,29). Pregnant migrants and migrating women of child-
bearing potential may be a source for pediatric HIV cases
in migrant-receiving nations.
The required medical examination for persons applying
for residence from abroad can precede their arrival in
Canada by up to 12 months, which raises the possibility of
new maternal HIV infection, the new conception of a
child, and new birth to HIV-infected mothers. The immi-
gration medical examination and processing represents a
time-limited opportunity to detect at-risk pregnancies to
provide treatment to prevent mother-to-child transmission
of HIV. The medical assessment, including HIV antibody
testing, may identify several groups of foreign-born
women at risk for transmitting HIV to their children,
including women with defined risk factors who are preg-
nant or may become pregnant during the immigration
application process, while in Canada or abroad.
An immigration application provides an opportunity to
inform and educate all applicants, particularly women of
childbearing potential, of the benefits of HIV screening in
pregnancy. Even women who test negative for HIV anti-
bodies during the immigration medical examination
should be retested if they become pregnant, whether they
are still abroad or have arrived in Canada. The medical
examination is also an opportunity to identify resources for
HIV screening in pregnancy for these women, separate
from the immigration process, and the local access points
for maternal management and, if needed, antiretroviral
treatment to reduce the risk for perinatal HIV transmission.
Three of the 4 children who received HAART in this study
did so in Western countries. None of the remaining 32
HIV-infected children, all of whom were in developing
nations, had any indication of receiving HAART for either
prevention or treatment.
Opportunities for active, programmatic intervention to
protect the health of pregnant women and reduce the risk
for HIV infection and transmission during pregnancy exist
for both refugees and refugee claimants on the basis of
their category of application. By definition, refugees have
already had their status determined and have already come
under the jurisdiction of a national or international author-
ity, such as the United Nations High Commission for
Refugees. Programs on health promotion and HIV infec-
tion and disease prevention in pregnant women and
women of childbearing potential can be part of the interna-
tional protection offered to this vulnerable population (30).
In this study, 72% of all pediatric HIV infections were in
the refugee category.
By definition, refugee claimants and asylum seekers
make their applications from within the host country. In
Canada, refugee claimants are provided access to health-
care services while their claim is determined. In spite of
the challenges of providing culturally and linguistically
accessible healthcare programs for foreign-born, migrant
women, this situation offers an opportunity to educate and
test pregnant applicants. In this study, one 6-year-old
refugee claimant with HIV, who traveled from Africa,
received HAART in Canada.
Other risk groups include women known to be HIV
positive and their children with risks for exposure to HIV
infection, such as breastfeeding; children with risk factors
for HIV infection other than birth to an HIV-positive moth-
er; and foreign-born children being adopted. Failure to rec-
ognize and use these opportunities may have implications
for maternal and pediatric HIV infection in migrant popu-
lations.
HIV antibody testing in immigrants is primarily a part
of the administrative process of determining the medical
status of migrants in accordance with immigration legisla-
tion (31,32). As such, it may not be directly linked to
HIV/AIDS clinical management programs. Routine immi-
gration testing for diseases such as HIV/AIDS or tubercu-
losis provides an opportunity to identify groups at
increased risk that may benefit from specific health promo-
tion and disease prevention programs (33).
Emerging Pediatric HIV Epidemic Related to Migration
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 4, April 2006 615Given the emerging patterns of global HIV/AIDS epi-
demiology and current immigration patterns, similar situa-
tions could be observed over time in other locations. A
proportional shift in total and pediatric HIV cases related
to foreign-born migrant arrivals in immigrant-receiving
nations, where cases in children are less common, can be
anticipated. Migrants, and the communities of newly
arrived persons that they tend to gravitate to, often have
health needs that may differ substantially from those of the
host population. The shifting demographics of pediatric
HIV infection in Canada can thus be expected to influence
local aspects of healthcare planning and delivery. The mul-
ticultural aspects of HIV infection in immigrants will
affect case management by local public health authorities,
social services, clinical pediatric HIV/AIDS services, and
other health and social service providers. Existing pro-
grams, designed in the context of domestically acquired
infections, may not have considered either the size of the
population or the culturally and linguistically diverse char-
acteristics of immigrant, HIV-infected children. Other
unanticipated program effects, including policy expecta-
tions from the international community on the medical,
cultural, and social aspects of pediatric HIV/AIDS and
immigration should receive greater attention (34,35).
One of the potential consequences of this shared knowl-
edge related to pediatric HIV and AIDS for domestic pro-
gram development could be the integration of immigration
medical programs and public health programs to prevent
mother-to-child transmission of HIV overseas. Only 4
(11%) of 36 of HIV-infected children received specific anti-
retroviral therapy, and none of the 12 HIV-positive children
who were <1 year of age, nor their mothers, were known to
have received perinatal HAART to prevent HIV transmis-
sion (36,37). Programs and strategies designed to mitigate
some infectious disease risks in migrant populations before
arrival have already been used in some situations (38); sim-
ilar rationales could be evaluated for HIV infection in those
already involved in immigration formalities.
The analysis and opinions expressed in this article are those
of the authors and are not to be attributed to Citizenship and
Immigration Canada or the government of Canada, and they do
not necessarily reflect or represent the position of any govern-
ment department, agency, university, or professional society to
which the authors may belong or have belonged.
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gencies, and migration. 
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